Checkpoint Therapeutics, Inc.
NASDAQ:CKPT
2.46 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.041 | 0 | 0.006 | 0.031 | 0.031 | 0.035 | 0.074 | 0.048 | 0.018 | 0.052 | 0.016 | 0.029 | 0.155 | 0.068 | 0.027 | 0.028 | 0.042 | 0.972 | 0.025 | 0.28 | 1.051 | 0.352 | 3.031 | 0.005 | 0.127 | 0.343 | 0.332 | 0.349 | 0.351 | 0.693 | 0.498 | 0.546 | 1.249 | 0.277 | 0.065 | 0.025 | 4.07 | 0.5 |
| Cost of Revenue
| 0 | 8.497 | 8.299 | 5.496 | 13.945 | 15.826 | 14.236 | 8.866 | 12.053 | 14.67 | 27.658 | 9.384 | 7.198 | 4.213 | 8.607 | 2.386 | 3.029 | 2.635 | 6.73 | 3.894 | 4.12 | 4.581 | 13.421 | 7.848 | 5.453 | 6.932 | 4.916 | 4.955 | 5.506 | 3.704 | 7.743 | 4.713 | 5.446 | 2.365 | 7.443 | 1.414 | 2.035 | 2.035 |
| Gross Profit
| 0.041 | -8.497 | -8.293 | -5.465 | -13.914 | -15.791 | -14.162 | -8.818 | -12.035 | -14.618 | -27.642 | -9.355 | -7.043 | -4.145 | -8.58 | -2.358 | -2.987 | -1.663 | -6.705 | -3.614 | -3.069 | -4.229 | -10.39 | -7.843 | -5.326 | -6.589 | -4.584 | -4.606 | -5.155 | -3.011 | -7.245 | -4.167 | -4.197 | -2.088 | -7.378 | -1.389 | 2.035 | -1.535 |
| Gross Profit Ratio
| 1 | 0 | -1,382.167 | -176.29 | -448.839 | -451.171 | -191.378 | -183.708 | -668.611 | -281.115 | -1,727.625 | -322.586 | -45.439 | -60.956 | -317.778 | -84.214 | -71.119 | -1.711 | -268.2 | -12.907 | -2.92 | -12.014 | -3.428 | -1,568.6 | -41.937 | -19.21 | -13.807 | -13.198 | -14.687 | -4.345 | -14.548 | -7.632 | -3.36 | -7.538 | -113.508 | -55.56 | 0.5 | -3.07 |
| Reseach & Development Expenses
| 4.48 | 8.497 | 8.299 | 5.496 | 13.945 | 15.826 | 14.236 | 8.866 | 12.053 | 14.67 | 27.658 | 9.384 | 7.198 | 4.213 | 8.145 | 2.543 | 3.029 | 2.635 | 6.73 | 3.894 | 4.12 | 4.581 | 13.421 | 7.848 | 5.453 | 6.932 | 4.916 | 4.955 | 5.506 | 3.704 | 7.743 | 4.713 | 5.446 | 2.365 | 5.359 | 3.485 | 0.444 | 2.035 |
| General & Administrative Expenses
| 2.234 | 2.451 | 1.876 | 2.236 | 2.281 | 2.292 | 2.482 | 1.846 | 2.129 | 2.243 | 2.128 | 1.923 | 2.114 | 2.373 | 2.124 | 2.429 | 1.687 | 1.678 | 2.152 | 1.62 | 1.758 | 1.703 | 1.502 | 1.544 | 1.352 | 2.194 | 1.355 | 1.344 | 1.317 | 1.403 | 1.09 | 0.972 | 1.221 | 1.184 | 2.156 | 0.219 | 0.031 | 0.082 |
| Selling & Marketing Expenses
| 0 | 0.1 | 0.3 | 0 | 0 | 0 | 0.4 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.234 | 2.451 | 1.876 | 2.236 | 2.281 | 2.292 | 2.482 | 1.846 | 2.129 | 2.243 | 2.128 | 1.923 | 2.114 | 2.373 | 2.124 | 2.429 | 1.687 | 1.678 | 2.152 | 1.62 | 1.758 | 1.703 | 1.502 | 1.544 | 1.352 | 2.194 | 1.355 | 1.344 | 1.317 | 1.403 | 1.09 | 0.972 | 1.221 | 1.184 | 2.156 | 0.219 | 0.031 | 0.082 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 6.714 | 10.948 | 10.175 | 7.732 | 16.226 | 18.118 | 16.718 | 10.712 | 14.182 | 16.913 | 29.786 | 11.307 | 9.312 | 6.586 | 10.269 | 4.972 | 4.716 | 4.313 | 8.882 | 5.514 | 5.878 | 6.284 | 14.923 | 9.392 | 6.805 | 9.126 | 6.271 | 6.299 | 6.823 | 5.107 | 8.833 | 5.685 | 6.667 | 3.549 | 7.515 | 3.704 | 2.51 | 0.082 |
| Operating Income
| -6.673 | -10.948 | -10.169 | -7.701 | -16.195 | -18.083 | -16.644 | -10.664 | -14.164 | -16.835 | -29.77 | -11.278 | -9.157 | -6.518 | -10.242 | -4.944 | -4.674 | -3.341 | -8.857 | -5.234 | -4.827 | -5.932 | -11.892 | -9.387 | -6.678 | -8.783 | -5.939 | -5.95 | -6.472 | -4.414 | -8.335 | -5.139 | -5.418 | -3.272 | -7.45 | -3.679 | -0.475 | -1.617 |
| Operating Income Ratio
| -162.756 | 0 | -1,694.833 | -248.419 | -522.419 | -516.657 | -224.919 | -222.167 | -786.889 | -323.75 | -1,860.625 | -388.897 | -59.077 | -95.853 | -379.333 | -176.571 | -111.286 | -3.437 | -354.28 | -18.693 | -4.593 | -16.852 | -3.923 | -1,877.4 | -52.583 | -25.606 | -17.889 | -17.049 | -18.439 | -6.369 | -16.737 | -9.412 | -4.338 | -11.812 | -114.615 | -147.16 | -0.117 | -3.234 |
| Total Other Income Expenses Net
| 0.003 | 0.003 | -8.959 | 1.977 | -0.357 | 7.609 | -4.378 | 0.052 | 0.022 | -0.013 | 0.014 | 0.013 | 0.013 | 0.013 | 0.017 | 0.014 | 0.029 | 0.06 | 0.031 | 0.028 | 0.035 | 0.042 | 0.273 | 0.043 | 0.039 | 0.018 | 0.021 | 0.022 | 0.024 | 0.031 | 0.012 | 0.011 | 0.013 | -0.333 | -0.601 | -0.07 | 0 | 0 |
| Income Before Tax
| -6.67 | -10.945 | -19.128 | -5.724 | -16.521 | -10.474 | -21.022 | -10.612 | -14.142 | -16.848 | -29.756 | -11.265 | -9.144 | -6.505 | -10.225 | -4.93 | -4.645 | -3.281 | -8.826 | -5.206 | -4.792 | -5.89 | -11.619 | -9.344 | -6.639 | -8.765 | -5.918 | -5.928 | -6.448 | -4.383 | -8.323 | -5.128 | -5.405 | -3.605 | -8.051 | -3.749 | -0.475 | -1.617 |
| Income Before Tax Ratio
| -162.683 | 0 | -3,188 | -184.645 | -532.935 | -299.257 | -284.081 | -221.083 | -785.667 | -324 | -1,859.75 | -388.448 | -58.994 | -95.662 | -378.704 | -176.071 | -110.595 | -3.376 | -353.04 | -18.593 | -4.559 | -16.733 | -3.833 | -1,868.8 | -52.276 | -25.554 | -17.825 | -16.986 | -18.37 | -6.325 | -16.713 | -9.392 | -4.327 | -13.014 | -123.862 | -149.96 | -0.117 | -3.234 |
| Income Tax Expense
| 0 | -0.043 | 15.341 | -7.701 | -0.031 | -7.609 | 4.343 | -0.104 | -0.044 | -0.026 | -0.014 | -0.054 | -0.056 | -0.055 | -0.055 | -0.053 | -0.051 | -0.047 | -0.046 | -0.045 | -0.041 | -5.932 | -11.892 | -9.387 | -6.678 | -8.783 | 0 | 0 | 0 | 0 | 0 | -5.139 | 0 | 0 | 0 | -3.679 | 0 | 0 |
| Net Income
| -6.67 | -10.945 | -19.128 | -5.724 | -16.521 | -2.865 | -25.365 | -10.508 | -14.098 | -16.822 | -29.756 | -11.265 | -9.144 | -6.505 | -10.225 | -4.93 | -4.645 | -3.281 | -8.826 | -5.206 | -4.792 | -5.89 | -11.619 | -9.344 | -6.639 | -8.765 | -5.918 | -5.928 | -6.448 | -4.383 | -8.323 | -5.128 | -5.405 | -3.605 | -8.051 | -3.749 | -0.475 | -1.617 |
| Net Income Ratio
| -162.683 | 0 | -3,188 | -184.645 | -532.935 | -81.857 | -342.77 | -218.917 | -783.222 | -323.5 | -1,859.75 | -388.448 | -58.994 | -95.662 | -378.704 | -176.071 | -110.595 | -3.376 | -353.04 | -18.593 | -4.559 | -16.733 | -3.833 | -1,868.8 | -52.276 | -25.554 | -17.825 | -16.986 | -18.37 | -6.325 | -16.713 | -9.392 | -4.327 | -13.014 | -123.862 | -149.96 | -0.117 | -3.234 |
| EPS
| -0.18 | -0.33 | -0.7 | -0.29 | -1.05 | -0.24 | -2.47 | -1.19 | -1.61 | -1.98 | -3.79 | -1.43 | -1.21 | -0.93 | -1.81 | -0.87 | -0.9 | -0.64 | -1.73 | -1.51 | -1.47 | -1.83 | -3.73 | -3.19 | -2.29 | -3.54 | -2.39 | -2.6 | -2.84 | -1.99 | -3.81 | -2.1 | -2.21 | -1.48 | -3.3 | -1.53 | -0.57 | -2.02 |
| EPS Diluted
| -0.18 | -0.33 | -0.7 | -0.29 | -1.05 | -0.24 | -2.47 | -1.19 | -1.61 | -1.98 | -3.79 | -1.43 | -1.21 | -0.93 | -1.81 | -0.87 | -0.9 | -0.64 | -1.73 | -1.51 | -1.47 | -1.83 | -3.6 | -3.19 | -2.29 | -3.54 | -2.39 | -2.6 | -2.84 | -1.99 | -3.77 | -2.1 | -2.21 | -1.48 | -3.3 | -1.53 | -0.57 | -2.02 |
| EBITDA
| -6.673 | -10.948 | -10.169 | -7.701 | -15.838 | -25.649 | -16.644 | -10.664 | -14.164 | -16.861 | -29.77 | -11.278 | -9.157 | -6.518 | -10.242 | -4.944 | -4.674 | -3.341 | -8.857 | -5.234 | -4.827 | -5.932 | -11.892 | -9.387 | -6.678 | -8.783 | -5.918 | -5.928 | -6.448 | -4.383 | -8.323 | -5.139 | -5.405 | -3.261 | -7.886 | -3.679 | 0 | 0 |
| EBITDA Ratio
| -162.756 | 0 | -1,694.833 | -248.419 | -510.903 | -732.829 | -224.919 | -222.167 | -786.889 | -324.25 | -1,860.625 | -388.897 | -59.077 | -95.853 | -379.333 | -176.571 | -111.286 | -3.437 | -354.28 | -18.693 | -4.593 | -16.852 | -3.923 | -1,877.4 | -52.583 | -25.606 | -17.825 | -16.986 | -18.37 | -6.325 | -16.713 | -9.412 | -4.327 | -11.773 | -121.323 | -147.16 | 0 | 0 |